It’s only fair to share… Elinzanetant CAS 929046-33-3 MW 668.6 g/mol MF C33H35F7N4O3 N-[6-[(7S,9aS)-7-(hydroxymethyl)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)-3-pyridinyl]-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide FDA 10/24/2025, Lynkuet, To treat moderate-to-severe vasomotor symptoms due to menopause BAY-3427080; GSK-1144814; NT-814, UNII-NZW2BOW35N Elinzanetant, sold under the brand name Lynkuet, is a medication used for the treatment of moderate to severe vasomotor symptoms due to menopause.[4] It is an neurokinin 1 and neurokinin 3 receptor antagonist.[4] It was developed by Bayer …